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Abstract  
In this proof-of-principle study a label-free optical sensor is demonstrated to monitor the 
surface adhesion of extracellular vesicles secreted by live cells on to various extracellular 
matrix proteins.  
 
1. Introduction 
Sensitive monitoring of the presence and interactions of biological objects at the nanometer length 
scale is increasingly important for both basic research and industrial applications. Following 
refractive index variations caused by the biological object itself is an emerging strategy to create 
optical sensors where any further labelling of biomolecules or living cells is unnecessary. This 
approach may open the way for a natural, reliable and cost-effective investigation of nanosized 
structures.
1 
 
Most of the label-free optical sensors are exploiting a surface bound evanescent wave to follow the 
refractive index variations.
2
 The evanescent wave is localised in the close vicinity of the sensor 
surface, making it ideal for in situ monitoring of surface adhesion processes. A relatively well-
known evanescent wave sensor is the Surface Plasmon Resonance (SPR) using a gold film. 
However, planar optical waveguides offer higher sensitivities.
3,4
 The typical depth of penetration for 
a waveguide mode at optical frequencies is 80-300 nm. In contrast to SPR, using waveguides the 
penetration depth can be easily tuned through waveguide design, matching in this way the sensing 
depth to the size of the adsorbed object.
5,6,7
  
 
An emerging area where the label-free surface sensitive sensors could be exploited is the interaction 
of extracellular vesicles (EVs) with model surfaces, biomolecules, polymers and receptors. 
Extracellular vesicles are cell-derived membrane surrounded structures of various sizes. The two 
most extensively characterized types of EVs are the exosomes (50-100 nm vesicles generated by the 
exocytosis of multivesicular bodies) and microvesicles (MVs, plasma membrane-derived 100-1000 
nm in diameter, often also referred to as shedding microvesicles, microparticles or ectosomes). The 
field of EVs represents one of the most rapidly emerging research areas in current biomedicine. 
These membrane bound structures are recently recognized conveyors of intercellular 
communication mediated either by membrane proteins or by their mRNA and microRNA cargo.
8,9
 
The size range of EVs does not match that of the detection of instruments used in conventional cell 
biology and clinical diagnostic laboratories. Thus, there is a sudden demand and an intensive 
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methodology development worldwide to meet these unmet needs. The evanescent field-based 
highly sensitive sensors may provide an exciting detection system for EVs. 
 
We have recently introduced Grating Coupled Interferometry (GCI), a label-free evanescent-field 
based optical sensing concept.
10-12
 The sensing strategy combines cost-effectiveness, simplicity and 
reliability of grating-coupled planar optical waveguides with the high resolution of interferometric 
measurements. The heart of the GCI technology is a high quality planar optical waveguide shown in 
Fig. 1. In order to fabricate the sensor chip, 3 gratings are etched into a glass support, and the glass 
is coated with a Ta2O5 waveguide film of 155 nm thickness. Next, a relatively thick layer of SiO2 is 
used to coat the entire waveguide surface, except for a 5 mm long aperture (see Fig. 1). This 
aperture serves as a sensing window of the device where the evanescent field of the waveguide 
mode can interact with the surface-adsorbed analytes. The present waveguide design with TE 
polarization gives a penetration depth of 80 nm into the cover media. The bulk refractive index 
sensitivity is 0.072, and the final refractive index resolution is approximately 10
-7
. 
 
In this work we demonstrate the use of GCI in the field of EV research. The biological question we 
addressed was whether MVs, secreted by the human CCRF-CEM T cell line (ECACC), bind to 
components of the extracellular matrix. As yet, there is very limited data available on the adhesion 
of EVs to matrix proteins.
13-15
 Several types of EVs carry adhesion molecules on their surface (for a 
meta-analysis see ref. 16). Most interestingly, the presence of integrins and proteins involved in 
integrin-mediated signaling are characteristic for the surface of MVs.
16
 Therefore we hypothesised 
that EVs bind to extracellular matrix molecules (such as type I collagen or fibronectin), enabling 
them to participate in tissue regeneration and repair, cell migration, inflammation and blood 
clotting.  
 
2. Materials and methods 
The methodology developed in the present work to monitor the interaction of MVs with matrix 
proteins is summarized schematically in Fig. 2. One million CCRF-CEM cells /mL were cultured in 
serum-free RPMI for 24 hours. The serum-free culture condition did not induce a significant 
apoptosis as confirmed by the absence of annexin V-FITC binding using flow cytometry (data not 
shown). The 24h conditioned medium was pelleted at 400g for 15 minutes to remove cells, and the 
supernatant was filtered through a 800 nm pore-sized filter (Millipore, Billerica, CA) by gravity. 
The filtered supernatant was centrifuged at 20,500g for 60 minutes to pellet MVs, as described 
previously.
17-21
 MVs were washed once in PBS filtered through a 0.1 μm pore-size filter. Protein 
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concentration of the MV preparations was measured by MicroBCA Proten Assay Kit (Pierce 
Biotechnology, Inc.). The average protein concentration in the samples used for GCI analysis was 
15 μg/mL. Samples were stored at -80 ºC until use, but for not longer than 2 weeks. Finally, the 
GCI sensor surface, coated with the biological molecule of interest, was exposed to the MV-
containing samples. 
 
To investigate the quality of the vesicle solution, shortly after centrifugation the supernatants were 
carefully removed, and the pellets were fixed at RT for 60 minutes with 4% PFA in 0.01 M PBS. 
After washing with PBS, the preparations were post-fixed in 1% OsO4 (Taab, Aldermarston, UK) 
for 30 minutes. Following rinsing with distilled water, the pellets were dehydrated in graded 
ethanol, including block-staining with 1% uranyl-acetate in 50% ethanol for 30 minutes, and 
embedded in Taab 812 (Taab). After overnight polymerization at 60 °C and sectioning for EM, the 
ultrathin sections were analyzed with a HITACHI 7100 electron microscope equipped by Megaview 
II (lower resolution, Soft Imaging System) digital camera. Fig. 3a demonstrates the excellent quality 
of the MV preparation. The size distribution of MVs was further analyzed using a scanning ion 
occlusion sensing approach (qNano, Izon Science Ltd., Christchurch, New Zealand).
22 
 
Samples were counted for 5 minutes using 7.15 mbar pressure. Voltage was set in between 0.1-0.25 
V in order to achieve a stable 100 nA current. Particle size histograms were recorded when RMS 
noise was below 12 pA, and particle rate in time was linear. Using the 200 and 400 nm pore 
membranes successively, most of the MVs were around 200-300 nm, but a smaller fraction of 
vesicles with larger diameters was also present (see Fig. 3b). This size range is in accordance with 
EM images in this study and previous findings.
17,23 
 
3. Results and discussions 
In order to monitor MV adsorption on to the GCI sensor, the cleaned sensor chip was first placed 
into an optical arrangement shown schematically in Fig. 1. Here, two beams of a linearly polarized 
He-Ne laser illuminate the 1
st
 and 2
nd
 gratings, which couple the waves into the planar optical 
waveguide. The second beam is phase modulated using a Liquid Crystal Modulator (LCM), 
creating a time-dependent interference signal after the 2
nd
 grating. This signal is outcoupled at the 
3
rd
 grating, and picked up by a fiber-coupled optical detector. The interference signal is analyzed by 
a personal computer, which calculates the phase shift the waveguide mode experienced at the 
sensing window of the chip. The temperature of the chip was stabilized with a Peltier-element at 
25
o
C. Over the sensing window a PEEK microcuvette with a Kalretz O-ring is mounted. The inlet 
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of this cuvette is equipped with a septum injection port in order to introduce minute amount of 
samples into the cuvette (see Fig. 1). The continuous washing of the sensor with pure buffer can be 
also done through the septum by using needle ended tubing (see Fig. 1). It is important to note that 
the septum was fixed by a special holder in order to minimize the mechanical disturbance of the 
interferometer during sample introduction.  
 
First, pure PBS was injected into the cuvette through the septum using a peristaltic pump and a 
fluidic tubing that ends up in a needle (see Fig. 1). After recording a stable baseline, the solutions of 
type I collagen (0.3mg/ml) and fibronectin (40µg/ml) (both from Sigma-Aldrich) were injected 
using a Hamilton syringe. The detected phase continuously increased (see Fig. 4a) indicating that 
the proteins were adsorbing on to the surface. After approx. 15 minutes, pure buffer was pumped 
into the cuvette again to wash off any irreversibly adsorbed proteins. Then, the MV containing 
sample was injected. MVs, adsorbing in the sensing window, increased the refractive index inside 
the evanescent field, thus, increasing the phase. After the MV exposure, again, pure buffer was 
flowed over the cuvette to remove any irreversibly adsorbed vesicles and the phase shift was 
recorded again. 
 
Fig. 4 shows the recorded phase shifts. As seen in the figure, the vesicles did not adsorb irreversibly 
on to the type I collagen coating. In contrast, an approximately 3 radians phase shift was observed 
with the fibronectin-coated sensor chip. Vesicle adsorption was also tested on bare and positively 
charged poly-L-lysine (PLL) coated waveguide surfaces. No irreversible adsorption was seen on the 
bare Ta2O5 chip, but the vesicles irreversibly bound to PLL causing a phase shift of 2.8 radians (see 
Fig. 4). This binding may be explained by the known externalization of the negatively charged 
phosphatidylserine by MVs.
17,18,23
 Our data suggest that PLL may be used to immobilize MVs, and 
may serve as an inexpensive alternative to annexin V. Importantly, we also showed that MVs bind 
to fibronectin. This is in line with the reported presence of integrins on the surface of leukocyte-
derived MVs that may possibly mediate the interaction with fibronectin. The observed failure of 
MVs to adsorb on to type I collagen coating might be related to the conformation of collagen on the 
surface of Ta2O5. It is important to stress that using the present optical arrangement 2x10
-4 
refractive 
index shift in the evanescent field corresponds to one radian phase shift in the recorder GCI signal. 
Therefore, considering the above phase shifts caused by the adsorbed MVs, one can conclude that 
high refractive index sensitivity is essential to resolve the signal of surface adsorbed MVs.  
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4. Conclusions 
In summary, in this proof-of-principle study a novel method was introduced to study EVs, and was 
used for monitoring of the interaction of cell-derived MVs with extracellular matrix molecules. The 
applied GCI technique is completely label-free; the vesicles were investigated in their native state. 
It is important to stress that EVs represent novel diagnostic biomarkers of various diseases. They 
are highly abundant in various biological fluids including blood plasma, urine, cerebrospinal fluid, 
synovial fluid, saliva, breast milk, etc. Their levels, protein compositions and miRNA signatures 
were shown to associate with numerous pathologies including tumors, autoimmune disorders, 
cardiovascular diseases, infections.
16
 However, their routine clinical analysis is limited, and thus, 
there is an urgent need for the development of new techniques for the analysis of EVs. In this study 
we investigated MV-extracellular matrix protein interaction in order to prove the applicability of 
GCI for EV analysis. Further applications of this novel technique include studying EV surface 
molecules by investigating the binding of EVs to antibody-coated surfaces as well as investigation 
of receptor-ligand interactions in the field of EVs. The GCI technique can be especially 
advantageous for the above applications since it not only offers superior refractive index sensitivity 
with excellent time resolution; but contains no moving parts, built up from simple and inexpensive 
components. After further developments the GCI technique could be made suitable for handheld 
devices as well as for high throughput screening instruments, facilitating industrial and diagnostic 
applications as well. 
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Figure captions 
 
Figure 1. Schematic cross-sectional illustration of the GCI sensor arrangement. The cuvette 
positioned above the optical waveguide sensor is equipped with a septum injection port for sample 
introduction using a Hamilton syringe. The washing off the irreversibly bound vesicles from the 
sensor by pure buffer is also done through the septum using a peristaltic pump equipped with needle 
ended tubing. The top view photograph of the GCI sensor chip is also shown. The two incoupling 
and the single outcoupling grating, as well as the 5 mm long sensing window, are clearly visible.  
 
Figure 2. Steps of isolation of MVs that were analyzed for their adhesion to the protein pre-coated 
GCI sensor surface. The surface adsorbed microvesicles are detected by the evanescent field of the 
propagating waveguide mode.  
 
Figure 3.(a) Transmission electron microphotograph of CCRF-CEM human cell line derived MVs 
(b) Size distribution of the MVs determined by scanning ion occlusion sensing approach. The size 
distribution curves were show combined data obtained by using the two single nanopore (200 and 
400 nm) membranes.  
 
Figure 4. (a) In-situ phase change during the coating process of the GCI sensor with collagen and 
fibronectin, followed by the introduction of the MV solution and subsequent washing with pure 
buffer. The coating with Poly-L-lysine (PLL) was not done in-situ, the waveguide was already 
coated when inserted into the GCI setup. The in situ phase signals, when the bare and the PLL 
coated waveguide was exposed to the MV solution, are also shown. The numbered arrows indicate: 
1) introduction of coating molecules, 2) washing off the irreversibly bound coating molecules using 
pure buffer, 3) injection of MV suspension, 4) washing off the irreversibly bound MVs using pure 
buffer (b) The recorded phase differences when the bare and the matrix protein or Poly-L-lysine 
(PLL)-coated GCI chip was exposed to the MV suspension (grey columns); the phase signals after 
washing off the MV suspension by pure buffer (black columns). 
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